Editor’s Choice-Clinical impact of delirium and antipsychotic therapy: 10-Year experience from a referral coronary care unit

Abstract

Background:

Little is known about safety of antipsychotic therapy for delirium in the coronary care unit (CCU). Our aim was to examine the effect of delirium and antipsychotic therapy among CCU patients.

Methods and results:

Pre-study Confusion Assessment Method-Intensive Care Unit (CAM–ICU) criteria were implemented in screening consecutive patients admitted to a referral CCU from 2004–2013. Death status was prospectively ascertained. Of 11,079 study patients, the incidence of delirium was 8.3% (n=925). Delirium was associated with an increased risk of in-hospital mortality (adjusted odds ratio (OR) 1.49; 95% confidence interval (CI), 1.08–2.08; p=0.02) and one-year mortality among patients who survived from CCU admission (adjusted hazard ratio (HR) 1.46; 95% CI, 1.12–1.87; p=0.005). A total of 792 doses of haloperidol (5 mg/day; interquartile range (IQR) 3–10) or quetiapine (25 mg/day; IQR 13–50) were given to 244 patients with delirium. The clinical characteristics of patients with delirium who did and did not receive antipsychotic therapy were not different (baseline corrected QT (QTc) interval 457±58 ms vs 459±60 ms, respectively; p=0.65). In comparison to baseline, mean QTc intervals after the first and third doses of the antipsychotics were not significantly prolonged in haloperidol (448±56, 458±57 and 450±50 ms, respectively) or quetiapine groups (470±66, 467±68 and 462±46 ms, respectively) (p>0.05 for all). Additionally, in-hospital mortality (adjusted OR 0.67; 95% CI, 0.42–1.04; p=0.07), ventricular arrhythmia (adjusted OR 0.87; 95% CI, 0.17–3.62; p=0.85) and one-year mortality among the hospital survivors (adjusted HR 0.86; 95% CI 0.62–1.17; p=0.34) were not different in patients with delirium irrespective of whether or not they received antipsychotics.

Conclusion:

In patients admitted to the CCU, delirium was associated with an increase in both in-hospital and one-year mortality. Low doses of haloperidol and quetiapine appeared to be safe, without an increase in risk of sudden cardiac death, in-hospital mortality, or one-year mortality in carefully monitored patients.

Keywords

Arrhythmias haloperidol mortality QTc interval quetiapine

Get full access to this article

View all access options for this article.

References

Khan

Zawahiri

Campbell

et al . Delirium in hospitalized patients: Implications of current evidence on clinical practice and future avenues for research–a systematic evidence review. J Hosp Med 2012; 7(7): 580–589.

Qassem

Milbrandt

. Clearing up the confusion: The results of two pilot studies of antipsychotics for ICU delirium. Crit Care 2010; 14(4): 316.

Ely

Inouye

Bernard

et al . Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286(21): 2703–2710.

Francis

Martin

Kapoor

. A prospective study of delirium in hospitalized elderly. JAMA 1990; 263(8): 1097–1101.

Leslie

Zhang

Holford

et al . Premature death associated with delirium at 1-year follow-up. Archives of Internal Medicine 2005; 165(14): 1657–1662.

McCusker

Cole

Abrahamowicz

et al . Delirium predicts 12-month mortality. Arch Intern Med 2002; 162(4): 457–463.

Beach

Celano

Noseworthy

et al . QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics 2013; 54(1): 1–13.

Ray

Chung

Murray

et al . Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360(3): 225–235.

Teodorescu

Reinier

Uy-Evanado

et al . Antipsychotic drugs are associated with pulseless electrical activity: The Oregon Sudden Unexpected Death Study. Heart Rhythm 2013; 10(4): 526–530.

10.

Devlin

Roberts

Fong

et al . Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebocontrolled pilot study. Crit Care Med 2010; 38(2): 419–427.

11.

Girard

Pandharipande

Carson

et al . Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Crit Care Med 2010; 38(2): 428–437.

12.

Barr

Fraser

Puntillo

et al . Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41(1): 263–306.

13.

Inouye

van Dyck

Alessi

et al . Clarifying confusion: The confusion assessment method. A new method for detection of delirium. Ann Int Med 1990; 113(12): 941–948.

14.

Singh

Ahmed

et al . Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records. Mayo Clin Proc 2012; 87(9): 817–824.

15.

Herasevich

Pickering

Dong

et al . Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc 2010; 85(3): 247–254.

16.

Knaus

Wagner

Draper

et al . The Apache-Iii Prognostic System – Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100(6): 1619–1636.

17.

Charlson

Pompei

Ales

et al . New method of classifying prognostic co-morbidity in longitudinal-studies – Development and validation. J Chronic Dis 1987; 40(5): 373–383.

18.

Vincent

Moreno

Takala

et al . The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22(7): 707–710.

19.

Sudden Arrhythmia Death Syndromes (SADS) Foundation, http://www.sads.org/living-with-sads/drugs-toavoid (2014, accessed 31 March 2014).

20.

Benoit

Mendelsohn

Nourjah

et al . Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 2005; 12(4): 363–368.

21.

DeVane

Nemeroff

. Clinical pharmacokinetics of quetiapine: An atypical antipsychotic. Clinical Pharmacokinetics 2001; 40(7): 509–5522.

22.

Kudo

Ishizaki

. Pharmacokinetics of haloperidol: An update. Clin Pharmacokinet 1999; 37(6): 435–456.

23.

Ancestry.com (2011) United States Social Security Death Index, 1935–2014. Provo, UT: Ancestry.com Operations Inc.

24.

Wentworth

Neaton

Rasmussen

. An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health 1983; 73(11): 1270–1274.

25.

Jones

Campbell

Patel

et al . Risk of mortality (including sudden cardiac death) and major cardiovascular events in users of olanzapine and other antipsychotics: A study with the General Practice Research Database. Cardiovasc Psychiatry Neurol 2013; 2013: 647476.

26.

Murray-Thomas

Jones

Patel

et al . Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: A study with the general practice research database. Cardiovasc Psychiatry Neurol 2013; 2013: 247486.

27.

Kim

Bader

Kotlyar

et al . Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003; 16(1): 29–31.

28.

Lee

Won

Lee

et al . Amisulpride versus quetiapine for the treatment of delirium: A randomized, open prospective study. Int Clin Psychopharmacol 2005; 20(6): 311–314.

29.

Maneeton

Srisurapanont

. An openlabel study of quetiapine for delirium. J Med Assoc Thai 2007; 90(10): 2158–2163.

30.

Pae

Lee

et al . A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol 2004; 19(2): 125–127.

31.

Sasaki

Matsuyama

Inoue

et al . A prospective, openlabel, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003; 64(11): 1316–1321.

32.

Woods

. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64(6): 663–667.

33.

Harrigan

Miceli

Anziano

et al . A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol 2004; 24(1): 62–69.

34.

Milbrandt

Kersten

Kong

et al . Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med 2005; 33(1): 226–229.

35.

Pun

Ely

. The importance of diagnosing and managing ICU delirium. Chest 2007; 132(2): 624–636.

36.

Czura

Friedman

Tracey

. Neural inhibition of inflammation: The cholinergic anti-inflammatory pathway. J Endotoxin Res 2013; 9(6): 409–413.

37.

Lieberman

Stroup

McEvoy

et al . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353(12): 1209–1223.

38.

Moots

Al-Saffar

Hutchinson

et al . Old drug, new tricks: Haloperidol inhibits secretion of proinflammatory cytokines. Ann Rheum Dis 1999; 58(9): 585–587.

39.

Song

Lin

Kenis

et al . Immunosuppressive effects of clozapine and haloperidol: Enhanced production of the interleukin-1 receptor antagonist. Schizophr Res 2000; 42(2): 157–164.

40.

Saczynski

Marcantonio

Quach

et al . Cognitive trajectories after postoperative delirium. N Engl J Med 2012; 367(1): 30–39.

41.

Dyer

Ashton

Teasdale

. Postoperative delirium. A review of 80 primary data-collection studies. Arch Intern Med 1995; 155(5): 461–465.

42.

McPherson

Wagner

Boehm

et al . Delirium in the cardiovascular ICU: Exploring modifiable risk factors. Crit Care Med 2013; 41(2): 405–413.

43.

Lee

Pannu

Reddy

et al . Delirium and early physical therapy (DEPTH) quality improvement (QI) in a coronary care unit (CCU). Am J Respir Crit Care Med 2014; 189: A2810.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB